XML 59 R35.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Note 1 - Description of Business and Corporate History (Details Textual) | Mar. 28, 2014 USD ($) shares | Mar. 07, 2014 | Sep. 30, 2013 shares | Dec. 31, 2015
--- | --- | --- | --- | ---
Reverse Stock Split [Member ] |  |  |  |
Stockholders' Equity Note, Stock Split, Conversion Ratio |  | 100 |  |
Paloma [Member] | Notes Payable, Other Payables [Member] |  |  |  |
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-term Debt and Accrued Interest | $ | $ 1,151,725 |  |  |
Paloma [Member] |  |  |  |
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 2,500,000 |  |  |
Vasculo Medics [Member] |  |  |  |
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares | 220,000 |  |  |
Canterbury and Hygeia [Member] |  |  |  |
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares |  |  | 1,150,116 |
Number of Businesses Acquired |  |  | 2 |
Number of Phase I Clinicial Trials Completed |  |  |  | 2

X
- Definition Amount of long-term debt due and accrued interest assumed at the acquisition date. + References No definition available. + Details
Name: | dffn_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongtermDebtAndAccruedInterest
Namespace Prefix: | dffn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of Phase I clinicial trials completed. + References No definition available. + Details
Name: | dffn_NumberOfPhaseIClinicialTrialsCompleted
Namespace Prefix: | dffn_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of businesses acquired by the entity during the period. + References No definition available. + Details
Name: | us-gaap_NumberOfBusinessesAcquired
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Stock Split -URI http://asc.fasb.org/extlink&oid=6525746 + Details
Name: | us-gaap_StockholdersEquityNoteStockSplitConversionRatio1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_NonmonetaryTransactionTypeAxis=dffn_ReverseStockSplitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=dffn_PalomaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=dffn_VasculoMedicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=dffn_CanterburyAndHygeiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |